A prospective open-label Phase 2 study of METYRAPONE as a preoperative treatment in patients with ACTH-independent Cushing's syndrome due to adrenal adenoma.
Latest Information Update: 02 Jun 2014
At a glance
- Drugs Metyrapone (Primary)
- Indications Cushing syndrome
- Focus Therapeutic Use
Most Recent Events
- 02 Jun 2014 New trial record